<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Shi R</submitter><journal>Signal transduction and targeted therapy</journal><pagination>16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7058617</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The identification of a CD47-blocking "hotspot" and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination.</pubmed_title><pmcid>PMC7058617</pmcid><pubmed_authors>Bi X</pubmed_authors><pubmed_authors>Yan J</pubmed_authors><pubmed_authors>Shi R</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Tan S</pubmed_authors><pubmed_authors>Gao GF</pubmed_authors><pubmed_authors>Huang Q</pubmed_authors><pubmed_authors>Chai Y</pubmed_authors><pubmed_authors>Duan X</pubmed_authors></additional><is_claimable>false</is_claimable><name>The identification of a CD47-blocking "hotspot" and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Mar</publication><modification>2026-04-29T13:16:51.033Z</modification><creation>2025-04-06T02:05:48.83Z</creation></dates><accession>S-EPMC7058617</accession><cross_references><pubmed>32296041</pubmed><doi>10.1038/s41392-020-0121-2</doi></cross_references></HashMap>